What happened
Abbott Laboratories saw its share price climb by 2%, according to a report from Sina Finance Express.
The increase is linked to a settlement agreement concerning infant formula.
Why it matters
A settlement can remove a source of legal uncertainty for a company, which may be read positively by investors.
The reported 2% move suggests the market viewed the resolution as favorable, though the source does not detail the settlement's terms or scope.
Key facts
Abbott's stock rose 2%.
The rise is tied to a settlement agreement involving infant formula.
The report originated from Sina Finance Express and was published by East Money.
What to watch next
Further details of the settlement agreement and any financial impact on Abbott.
Whether the stock movement holds or reverses as more information becomes available.